Abandoning hopelessness. Reform of the U.S. Food and Drug Administration (FDA).
Baker
R
R
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000998:Antiviral Agents / Q000138:chemical synthesis / Q000627:therapeutic use; D015195:Drug Design; D004348:Drug Labeling; D006801:Humans; D016134:Organizational Policy; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents